MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Monday, June 20, 2016

12:30pm-2:00pm
Treatment of lipopolysaccharide-induced parkinsonism

I. Niehaus (Rendsburg, Germany)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Triple stimulation technique findings in patients with Parkinson’s disease and multiple system atrophy

H. Wang, Q. Ding, J. Yuan, L. Cui (Beijing, People's Republic of China)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Twelve-week sensor assessment in Parkinson’s disease: Impact on quality of life

J.M.T. Van Uem, K.S. Maier, A.T. Santos, O. Fagerbakke, F. Larsen, J.J. Ferreira, W. Maetzler (Tübingen, Germany)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Two years after unilateral Forel’s H campotomy for Parkinson’s disease: Quality of life, motor and cognitive outcomes of eleven patients

F. Godinho, M.O. Oliveira, P. Terzian, C. Costa, P. Gordon, M.S. Rocha (São Paulo, Brazil)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Types of farming and prevalence and incidence of Parkinson’s disease: French nationwide study

S. Kab, J. Spinosi, L. Chaperon, A. Dugravot, A. Singh-Manoux, F. Moisan, A. Elbaz (Saint-Maurice, France)

Epidemiology and Quality of Life
12:30pm-2:00pm
Unawareness of causes of sudden deterioration in Parkinson’s patients in movement disorder clinic

V. Paramanandam, D.A. Olszewska, C. Fearon, B. Magennis, T. Lynch (Dublin, Ireland)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Understanding, predicting, and preventing falls in progressive supranuclear palsy

B.R. Bluett, I. Litvan, S. Cheng, J. Juncos, Y. Bordelon, D.E. Riley, D. Standaert, S.G. Reich, D.A. Hall, B. Kluger, D. Shprecher, C. Marras, J. Jankovic (Las Vegas, NV, USA)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Underutilization of physiotherapy for Parkinson’s disease in the United States

M.E. Fullard, D.P. Thibault, A. Hill, J. Fox, A.W. Willis (Philadelphia, PA, USA)

Epidemiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Unilateral dual lead thalamic deep brain stimulation improves refractory essential tremor

D. Isaacs, J.T. Butler, C. Tolleson, F. Phibbs, J. Fang, P. Hedera (Nashville, TN, USA)

Surgical therapy: Other movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Unilateral focused ultrasound thalamotomy in tremor-dominant Parkinson’s disease

B.B. Shah, D.S. Huss, S. Sperling, M.B. Harrison, J. Elias (Charlottesville, VA, USA)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley